Willow Biosciences (FRA:3D7) 5-Year EBITDA Growth Rate : 51.10% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Willow Biosciences 5-Year EBITDA Growth Rate?

Willow Biosciences's EBITDA per Share for the three months ended in Dec. 2023 was €-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 38.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 51.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 54.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Willow Biosciences was 78.90% per year. The lowest was -114.40% per year. And the median was 24.55% per year.

Competitive Comparison of Willow Biosciences's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Willow Biosciences's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Willow Biosciences's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Willow Biosciences's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Willow Biosciences's 5-Year EBITDA Growth Rate falls into.

Willow Biosciences 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Willow Biosciences (FRA:3D7) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Willow Biosciences 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences (FRA:3D7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (FRA:3D7) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CANSF:USA WLLW:Canada

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.

Willow Biosciences (FRA:3D7) Headlines

No Headlines